Search

Search Constraints

You searched for: Author/Creator Meijer, Sybren L.

Search Results

1. Aberrant TP53 detected by combining immunohistochemistry and DNA‐FISH improves Barrett's esophagus progression prediction: A prospective follow‐up study. Issue 2 (4th October 2014)

2. Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study. Issue 6 (4th December 2021)

3. Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study. Issue 6 (December 2021)

5. Barrett's esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progression. Issue 8 (6th July 2021)

6. Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma. Issue 10 (7th May 2019)

7. Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma. Issue 5 (13th August 2019)

8. Genetic Abnormalities in Biliary Brush Samples for Distinguishing Cholangiocarcinoma from Benign Strictures in Primary Sclerosing Cholangitis. (3rd April 2016)

9. Impact of increasing lymph node yield on staging, morbidity and survival after esophagectomy for esophageal adenocarcinoma. Issue 1 (January 2023)

10. Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma. Issue 9 (5th October 2021)